Back to Awarded Treatment Trials


Awarded Trial: 13T-015

Grant ID

13T-015

Illness

schizophrenia

Primary Drug/Intervention

canakinumab

Primary Dosage

N/A

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Weickert

Sample Size

30

Duration of Study Period for Each Subject

56 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Thomas Weickert

Degree

N/A

Center

Neuroscience Research Australia

Institution

University of New South Wales

Address

Barker Street

City or Town

Randwick

State or Province

New South Wales

Zip or Postal Code

2031

Country

Australia

Email Address

t.weickert@neura.edu.au